These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22949242)

  • 1. Surface characterisation of biofouled NF membranes: role of surface energy for improved rejection predictions.
    Botton S; Verliefde AR; Quach NT; Cornelissen ER
    Water Sci Technol; 2012; 66(10):2122-30. PubMed ID: 22949242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of biofouling on pharmaceuticals rejection in NF membrane filtration.
    Botton S; Verliefde AR; Quach NT; Cornelissen ER
    Water Res; 2012 Nov; 46(18):5848-60. PubMed ID: 22960036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rejection of pharmaceutically active compounds and endocrine disrupting compounds by clean and fouled nanofiltration membranes.
    Yangali-Quintanilla V; Sadmani A; McConville M; Kennedy M; Amy G
    Water Res; 2009 May; 43(9):2349-62. PubMed ID: 19303127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct observation of bacterial deposition onto clean and organic-fouled polyamide membranes.
    Subramani A; Huang X; Hoek EM
    J Colloid Interface Sci; 2009 Aug; 336(1):13-20. PubMed ID: 19406423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and effect of biofouling on polyamide reverse osmosis and nanofiltration membrane surfaces.
    Khan MM; Stewart PS; Moll DJ; Mickols WE; Nelson SE; Camper AK
    Biofouling; 2011 Feb; 27(2):173-83. PubMed ID: 21253926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A QSAR model for predicting rejection of emerging contaminants (pharmaceuticals, endocrine disruptors) by nanofiltration membranes.
    Yangali-Quintanilla V; Sadmani A; McConville M; Kennedy M; Amy G
    Water Res; 2010 Jan; 44(2):373-84. PubMed ID: 19616272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated approach for biofouling control.
    Vrouwenvelder JS; Kruithof JC; Van Loosdrecht MC
    Water Sci Technol; 2010; 62(11):2477-90. PubMed ID: 21099033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of electrostatic interactions on the rejection with NF and assessment of the removal efficiency during NF/GAC treatment of pharmaceutically active compounds in surface water.
    Verliefde AR; Heijman SG; Cornelissen ER; Amy G; Van der Bruggen B; van Dijk JC
    Water Res; 2007 Aug; 41(15):3227-40. PubMed ID: 17583761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection of pharmaceuticals by forward osmosis membranes.
    Jin X; Shan J; Wang C; Wei J; Tang CY
    J Hazard Mater; 2012 Aug; 227-228():55-61. PubMed ID: 22640821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The construction of a zwitterionic PVDF membrane surface to improve biofouling resistance.
    Shen X; Zhao Y; Chen L
    Biofouling; 2013 Sep; 29(8):991-1003. PubMed ID: 23952818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fouling of reverse osmosis and nanofiltration membranes by dairy industry effluents.
    Turan M; Ates A; Inanc B
    Water Sci Technol; 2002; 45(12):355-60. PubMed ID: 12201123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined coagulation-disk filtration process as a pretreatment of ultrafiltration and reverse osmosis membrane for wastewater reclamation: an autopsy study of a pilot plant.
    Chon K; Kim SJ; Moon J; Cho J
    Water Res; 2012 Apr; 46(6):1803-16. PubMed ID: 22310806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of dairy wastewater by two-stage membrane operation with ultrafiltration and nanofiltration.
    Gong YW; Zhang HX; Cheng XN
    Water Sci Technol; 2012; 65(5):915-9. PubMed ID: 22339027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
    Kimura K; Iwase T; Kita S; Watanabe Y
    Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of laboratory water quality for studying initial bacterial adhesion during NF filtration processes.
    Semião AJ; Habimana O; Cao H; Heffernan R; Safari A; Casey E
    Water Res; 2013 May; 47(8):2909-20. PubMed ID: 23541307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of membrane fouling for in-line filtration of oil sands process-affected water: the effects of pretreatment conditions.
    Kim ES; Liu Y; Gamal El-Din M
    Environ Sci Technol; 2012 Mar; 46(5):2877-84. PubMed ID: 22279959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the effect of charge density in the active layers of reverse osmosis and nanofiltration membranes on the rejection of arsenic(III) and potassium iodide.
    Coronell O; Mi B; Mariñas BJ; Cahill DG
    Environ Sci Technol; 2013 Jan; 47(1):420-8. PubMed ID: 23199291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of clindamycin from fermentation wastewater with nanofiltration membranes.
    Zhu A; Zhu W; Wu Z; Jing Y
    Water Res; 2003 Sep; 37(15):3718-32. PubMed ID: 12867340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distillery wastewater treatment by the membrane-based nanofiltration and reverse osmosis processes.
    Nataraj SK; Hosamani KM; Aminabhavi TM
    Water Res; 2006 Jul; 40(12):2349-56. PubMed ID: 16757012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.